SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $24,582,000 | +14.0% | 1,641,004 | -7.4% | 0.01% | +18.2% |
| Q1 2016 | $21,571,000 | -54.7% | 1,772,444 | -40.7% | 0.01% | -54.2% |
| Q4 2015 | $47,566,000 | -20.3% | 2,989,568 | -23.2% | 0.02% | -17.2% |
| Q3 2015 | $59,665,000 | -41.2% | 3,891,957 | -6.7% | 0.03% | -37.0% |
| Q2 2015 | $101,463,000 | +9.4% | 4,173,680 | +4.6% | 0.05% | +9.5% |
| Q1 2015 | $92,744,000 | -16.3% | 3,989,011 | -9.6% | 0.04% | -16.0% |
| Q4 2014 | $110,807,000 | -37.4% | 4,412,832 | -22.4% | 0.05% | -38.3% |
| Q3 2014 | $176,899,000 | +8.2% | 5,688,153 | -10.0% | 0.08% | +12.5% |
| Q2 2014 | $163,440,000 | +22.7% | 6,320,293 | +10.9% | 0.07% | +14.3% |
| Q1 2014 | $133,232,000 | +16.1% | 5,701,029 | +26.1% | 0.06% | +12.5% |
| Q4 2013 | $114,718,000 | +42.4% | 4,520,018 | +14.4% | 0.06% | +30.2% |
| Q3 2013 | $80,586,000 | – | 3,950,337 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |